Cephalexin is not an effective treatment for bacterial vaginosis (BV). It belongs to the cephalosporin class of antibiotics, and research published in the American Society for Microbiology found that cephalosporins have poor activity against Gardnerella vaginalis, the primary bacterium responsible for BV. No major medical guidelines recommend cephalexin for this condition.
Why Cephalexin Doesn’t Work for BV
BV is caused by an overgrowth of anaerobic bacteria, particularly Gardnerella vaginalis, that displace the healthy lactobacillus bacteria normally found in the vagina. Cephalexin is a broad-spectrum antibiotic designed to target a different set of bacteria. It works well against many common infections like skin infections and urinary tract infections, but the bacteria behind BV are largely resistant to it.
Beyond being ineffective against BV-causing bacteria, cephalexin can actually make things worse. As a broad-spectrum antibiotic, it suppresses the protective lactobacillus species in the vagina. These bacteria maintain an acidic environment that keeps harmful organisms in check. When lactobacillus populations drop, yeast like Candida can overgrow, potentially leaving you with a yeast infection on top of untreated BV.
Why People Confuse the Two
If you were prescribed cephalexin for a UTI and are now wondering whether it will also clear up BV symptoms, you’re not alone. The two conditions share overlapping symptoms, including discomfort or burning during urination. BV adds distinct signs like a thin grayish-white discharge with a strong fishy odor, especially after sex. UTIs, by contrast, typically cause frequent urination, urgency, and cloudy or bloody urine without unusual vaginal discharge. If you’re experiencing symptoms of both, each condition needs its own targeted treatment.
What Actually Treats BV
The CDC recommends two main antibiotics for BV: metronidazole and clindamycin. Both are available as oral pills or vaginal formulations, and they specifically target the anaerobic bacteria responsible for the infection.
Oral metronidazole taken twice daily for seven days produces cure rates around 70%. Oral clindamycin on the same schedule has shown cure rates as high as 85% in clinical trials. Vaginal clindamycin cream achieves roughly 63 to 64% cure rates whether given as a single dose or a seven-day course. A newer option, secnidazole, offers the convenience of a single oral dose, though its cure rate in trials was more modest at about 53%.
These medications work because they are specifically designed to kill anaerobic bacteria while doing less damage to the beneficial lactobacillus that keep the vaginal environment healthy. That targeted approach is exactly what makes them effective where cephalexin falls short.
Risks of Using the Wrong Antibiotic
Taking cephalexin for BV isn’t just ineffective. Leaving BV untreated (or poorly treated) carries real health consequences. Untreated BV increases your risk of contracting HIV and other sexually transmitted infections like chlamydia and gonorrhea. If you’re pregnant, BV raises the chance of preterm delivery. The bacteria involved can also travel upward and cause pelvic inflammatory disease, which can lead to long-term fertility problems.
Using an antibiotic that doesn’t address the actual infection also contributes to antibiotic resistance without any benefit. You get the side effects, the disruption to your body’s normal bacterial balance, and potentially a secondary yeast infection, all while the original problem persists.
Getting the Right Diagnosis
BV is diagnosed through a vaginal swab, not a urine test. If you’re experiencing unusual discharge, a fishy smell, or vaginal burning, those symptoms point toward BV or a yeast infection rather than a UTI. A healthcare provider can distinguish between these conditions quickly with a simple exam and determine which antibiotic, if any, you actually need. Starting the right treatment from the beginning avoids the cycle of ineffective antibiotics and worsening symptoms.